RELX International
Donald Graff is a seasoned professional in scientific affairs, currently serving as the Head of Scientific Affairs for North America at RELX International since January 2021. Prior to this role, Graff held similar positions at RELX Technology and served as Principal Scientist at JUUL Labs. With extensive experience in tobacco research at Celerion and a background in pharmacology from the US EPA, Graff also possesses a robust academic foundation with post-doctoral fellowships at the University of North Carolina at Chapel Hill and a pharmacy practice residency at the University of Nebraska Medical Center, where Graff earned a PharmD.
This person is not in any teams
This person is not in any offices
RELX International
3 followers
Established in 2019, RELX International is a global leader and pioneer in the e-cigarette industry. Available in over 40 countries, RELX International now serves over 22 million adult smokers globally. Within 4 years of operation, RELX International has claimed leadership positions in major markets including Spain, Italy, the Philippines, Korea, and Colombia, with a global point-of-sale presence exceeding 150,000 and over 25,000 RELX retail stores. RELX International offers world-class vaping solutions through an innovative dual-brand product portfolio: RELX and WAKA. To ensure superior product quality, all RELX and WAKA products are designed and rigorously tested at a cutting-edge R&D centre and produced at one of the world’s largest e-cigarette factories, fully owned by RELX. As a commitment to corporate accountability, RELX International pledges to contribute to the communities where it operates under its three key pillars of: Guardian Program, Golden Shield, and Green Shoots. With trust from over 22 million adult smokers and 150 trade partners, RELX International is dedicated to providing cutting-edge harm reduction solutions for legal age users around the world.